Veru Inc. (NASDAQ: VERU) May Be Attracting Institutional Investments

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Veru Inc. (VERU) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by +$0.005, or +0.05%, to $10.71. Volume reached 46,172 shares, with price reaching a high of $10.79 and a low of $10.67. Recently, Yahoo Finance discussed the stock, revealing that Veru to Participate in the Cantor Oncology, Hematology & HemeOnc Conference on September 28th, 2022.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.

Sponsored

Stocks Info

Veru Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. At the end of the last regular session, the stock closed at $10.67 and fluctuated between $10.85 as its day high and $10.36 as its day low. The current market capitalization of Veru Inc. is $907.80M. A total of 2.91 million shares were traded on the day, compared to an average of 9.02M shares.

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, VERU has seen 4 BUY and 1 SELL insider trades, representing the acquisition of 100,000 and the disposition of 100,000 shares. Over the last 12 months, there were 4 BUYs and 1 SELLs from insiders. Insiders purchased 100,000 shares during that period but sold 100,000.

In the most recent transaction, Eisenberger Mario sold 100,000 shares of VERU for 20.04 per share on Aug 15. After the transaction, the Director now owns 0 company shares.

Dividend

It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. VERU’s most recent ex-dividend date was 04/28/2014 when it declared a $0.07 quarterly dividend that was paid in cash on 05/07/2014. Previously, the company paid the dividend on 02/05/2014 with an ex-dividend date of 01/27/2014. The dividend was $0.07 per share in cash.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for VERU in the last 3 months, the mean price target is $35.20 with high estimates of $55.00 and low estimates of $24.00. In terms of 52-week highs and lows, VERU has a high of $24.55 and a low of $4.34.

As of this writing, VERU has an earnings estimate of $-0.29 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of $-0.27 per share and a lower estimate of $-0.3. The company reported an EPS of $-0.28 in the last quarter, which was -55.56% lower than expectations of $-0.18.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 5 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VERU is Overweight with a score of 5.00. A total of 5 analysts rated the stock as Buy while 0 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

292
294

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.